Sun Pharma Q2FY27: Standalone Profit Jumps 54%

Sun Pharmaceutical Industries has announced its results for the second quarter ended September 30, 2026 (Q2FY27), with profit trends differing between its standalone and consolidated numbers. On a standalone basis, net profit jumped 54.42% to Rs 871.29 crore, compared with Rs 564.22 crore in the same quarter last year. Total income rose 34.67% to Rs 6,222.93 crore from Rs 4,620.90 crore a year earlier. On a consolidated basis, net profit declined 36.22% to Rs 1,988.53 crore from Rs 3,117.95 crore in the year-ago quarter. However, total income grew 11.83% to Rs 16,716.03 crore, up from Rs 14,948.23 crore in Q2FY26. Disclaimer: Investments in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. The above information is for educational and learning purpose. They analyst or his associates do not hold any shares of the company and have no financial interest in it. SEBI Registered Research Analyst: Vineet Ashwinikumar Chawla: INH000008190, BSE Enlistment No: 5433